Nikko Asset Management Americas, Inc. - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 72 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q1 2019. The put-call ratio across all filers is 0.41 and the average weighting 0.5%.

Quarter-by-quarter ownership
Nikko Asset Management Americas, Inc. ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q3 2020$6,350,000
+634900.0%
58,656
-10.4%
0.06%
Q2 2020$1,000
-100.0%
65,463
-71.3%
0.00%
-100.0%
Q1 2020$24,658,000
+67.3%
228,454
+80.3%
0.23%
-0.4%
Q4 2019$14,743,000
-0.5%
126,678
-2.1%
0.23%
-11.8%
Q3 2019$14,818,000
+41.9%
129,445
+18.1%
0.26%
+28.3%
Q2 2019$10,445,000
+110.3%
109,599
+101.4%
0.20%
+56.5%
Q1 2019$4,966,00054,4230.13%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q1 2019
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 131,657$13,077,0005.92%
Point72 Hong Kong Ltd 103,797$10,310,0003.49%
York Capital Management Global Advisors, LLC 827,738$82,219,0002.00%
Parametrica Management Ltd 3,889$386,0001.83%
Athos Capital Ltd 35,266$3,503,0001.19%
Hillhouse Capital Management 618,391$61,425,0001.05%
JUPITER ASSET MANAGEMENT LTD 502,812$49,940,0000.73%
Black Creek Investment Management Inc. 240,232$23,862,0000.73%
COMGEST GLOBAL INVESTORS S.A.S. 243,652$24,202,0000.54%
Temasek Holdings (Private) Ltd 990,000$98,337,0000.52%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders